For years, doctors prescribed anti-nausea medication Zofran to pregnant women to prevent morning sickness without fully explaining the risks. Zofran was never approved to treat morning sickness and has been linked with numerous birth defects.
Studies suggest that women who take Zofran may be twice as likely to give birth to a child with a heart defect. Researchers are currently studying other potential side effects.
Over 20 years ago, Zofran was approved by the FDA to combat nausea and vomiting, but ONLY for chemotherapy and postoperative surgery patients. Without regard for safety, drug manufacturer GlaxoSmithKline offered financial incentives to doctors to prescribe Zofran for pregnant women.
Zofran was NEVER approved to treat morning sickness in pregnant women. Worse yet, unsuspecting patients who took Zofran weren’t properly warned about the risks and its effectiveness was exaggerated.
If you took Zofran while pregnant and your child suffered a birth defect, you may be entitled to financial compensation.